BCL7A and Burkitt lymphoma: Since then, various studies have confirmed that BCL7A is recurrently mutated in BL at frequencies of ~ 7% in coding regions and up to 43% when also considering non-coding regions, harboring mutational patterns consistent with aSHM [108, 138].